Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
42
datasets available to search
ShareScore release 0.9.0
Dataset results
42 results for “chp”
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02734771. IPD Sharing: NO. Countries: 1. Publications: 0.
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
ClinicalTrials.gov study NCT06743945. IPD Sharing: NO. Countries: 1. Publications: 0.
Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study
ClinicalTrials.gov study NCT07398638. IPD Sharing: NO. Countries: 1. Publications: 0.
Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS
ClinicalTrials.gov study NCT06925555. IPD Sharing: NO. Countries: 1. Publications: 0.
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
ClinicalTrials.gov study NCT06730542. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristin
ClinicalTrials.gov study NCT06717347. IPD Sharing: YES. Countries: 35. Publications: 0.
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06594939. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL
ClinicalTrials.gov study NCT07035379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
ClinicalTrials.gov study NCT06468943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
ClinicalTrials.gov study NCT04332822. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large
ClinicalTrials.gov study NCT05406401. IPD Sharing: YES. Countries: 7. Publications: 0.
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07078500. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participant
ClinicalTrials.gov study NCT04790903. IPD Sharing: NO. Countries: 4. Publications: 0.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell L
ClinicalTrials.gov study NCT06890884. IPD Sharing: YES. Countries: 9. Publications: 0.
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphom
ClinicalTrials.gov study NCT06047080. IPD Sharing: YES. Countries: 21. Publications: 0.
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
ClinicalTrials.gov study NCT04594798. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers
ClinicalTrials.gov study NCT00291473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transcriptomic analysis of Mtb H37Rrv and MtbΔwhiB4 upon treatment with 0.25 mM CHP
GEO Series GSE73877. Mycobacterium tuberculosis H37Rv. 11 samples. Type: Expression profiling by array.
H3K27ac, H3K4me and H3K4me3 binding examined by ChIP-seq in the CHP-134 neuroblastoma cell line
GEO Series GSE113139. Homo sapiens. 5 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
ClinicalTrials.gov study NCT04677426. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.